综合性方法阐明Cipadessa baccifera (Roth) Miq. 的抗糖尿病功效. :基于代谢学,网络药理学和动物模型的研究
Dibya Ranjan Sahoo1, Swaraj Kumar Babu1, Abhijit Sahu1
1Centre of Excellence in Natural Products and Therapeutics, Department of Biotechnology and Bioinformatics, Sambalpur University, Sambalpur, Odisha, India.
Chemistry & biodiversity
|January 8, 2026
概括
西帕德萨巴基菲拉通过改善葡萄糖调节和胰岛素水平,显示出显著的抗糖尿病作用. 这种传统的药物显示出作为管理糖尿病的天然补充剂的希望.
科学领域:
- 药理学 药理学是指药理学的学科.
- 植物化学 植物化学
- 代谢疾病 代谢疾病
背景情况:
- 传统上,Cipadessa baccifera (Meliaceae) 是用于糖尿病的药物.
- 需要对其抗糖尿病特性进行科学验证.
研究的目的:
- 为了验证C.baccifera的抗糖尿病功效.
- 阐明其潜在的作用机制.
主要方法:
- 超高性能液态染色学-四极飞行时间质谱学 (UPLC-Q-ToF/MS) 用于化合物识别.
- 在体外测试 (酶抑制,细胞毒性,MIN6细胞上的葡萄糖吸收).
- 在糖尿病模型中的体内研究,GLUT4表达的qRT-PCR和免疫染.
主要成果:
- UPLC-Q-ToF/MS确定了93种化合物;在分析中突出了关键的调节基因 (PPARG,AKT1,SIRT1,FOXO1).
- 与乙醇提取物观察到显著的酶抑制.
- 在体内研究显示血糖,胰岛素和HbA1c降低;GLUT4表达被上调.
结论:
- 西帕德萨巴基菲拉提取物表现出显著的抗糖尿病作用.
- 机理学研究表明,调节葡萄糖运输和胰岛素信号通路.
- C.baccifera显示出作为糖尿病管理的天然补充剂的潜力.
相关概念视频
Measurement of Bioavailability: Pharmacodynamic Methods
228
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
228
Model Approaches for Pharmacokinetic Data: Compartment Models
519
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
519
Dipeptidyl Peptidase 4 Inhibitors
575
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
575


